Buck AK - Search Results

1

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment.

Werner RA, Schmid JS, Muegge DO, Lückerath K, Higuchi T, Hänscheid H, Grelle I, Reiners C, Herrmann K, Buck AK, Lapa C. Werner RA, et al. Among authors: buck ak. Medicine (Baltimore). 2015 Nov;94(45):e2016. doi: 10.1097/MD.0000000000002016. Medicine (Baltimore). 2015. PMID: 26559299 Free PMC article.

2

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C, Schuster T, Geinitz H, Treiber U, Schwaiger M. Krause BJ, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):18-23. doi: 10.1007/s00259-007-0581-4. Epub 2007 Sep 22. Eur J Nucl Med Mol Imaging. 2008. PMID: 17891394

3

In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors.

Herrmann K, Eckel F, Schmidt S, Scheidhauer K, Krause BJ, Kleeff J, Schuster T, Wester HJ, Friess H, Schmid RM, Schwaiger M, Buck AK. Herrmann K, et al. Among authors: buck ak. J Nucl Med. 2008 Sep;49(9):1437-44. doi: 10.2967/jnumed.108.052027. Epub 2008 Aug 14. J Nucl Med. 2008. PMID: 18703612 Free article.

4

[Imaging procedures for gastrointestinal stromal tumors].

Antoch G, Herrmann K, Heusner TA, Buck AK. Antoch G, et al. Among authors: buck ak. Radiologe. 2009 Dec;49(12):1109-16. doi: 10.1007/s00117-009-1852-9. Radiologe. 2009. PMID: 19787329 Review. German.

5

Pancreatic and hepatobiliary cancers.

Buck AK, Herrmann K, Eckel F, Beer AJ. Buck AK, et al. Methods Mol Biol. 2011;727:243-64. doi: 10.1007/978-1-61779-062-1_14. Methods Mol Biol. 2011. PMID: 21331938

6

PET/CT for staging lung cancer: costly or cost-saving?

Buck AK, Herrmann K, Schreyögg J. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2011 May;38(5):799-801. doi: 10.1007/s00259-011-1803-3. Epub 2011 Mar 26. Eur J Nucl Med Mol Imaging. 2011. PMID: 21442260 No abstract available.

7

Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.

Herrmann K, Buck AK, Schuster T, Junger A, Wieder HA, Graf N, Ringshausen I, Rudelius M, Wester HJ, Schwaiger M, Keller U, Dechow T. Herrmann K, et al. Among authors: buck ak. J Nucl Med. 2011 May;52(5):690-6. doi: 10.2967/jnumed.110.084566. Epub 2011 Apr 15. J Nucl Med. 2011. PMID: 21498532 Free article. Clinical Trial.

8

Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.

Ott K, Herrmann K, Schuster T, Langer R, Becker K, Wieder HA, Wester HJ, Siewert JR, zum Büschenfelde CM, Buck AK, Wilhelm D, Ebert MP, Peschel C, Schwaiger M, Lordick F, Krause BJ. Ott K, et al. Among authors: buck ak. Ann Surg Oncol. 2011 Nov;18(12):3316-23. doi: 10.1245/s10434-011-1743-y. Epub 2011 May 3. Ann Surg Oncol. 2011. PMID: 21537865

9

Facing the nuclear threat: thyroid blocking revisited.

Hänscheid H, Reiners C, Goulko G, Luster M, Schneider-Ludorff M, Buck AK, Lassmann M. Hänscheid H, et al. Among authors: buck ak. J Clin Endocrinol Metab. 2011 Nov;96(11):3511-6. doi: 10.1210/jc.2011-1539. Epub 2011 Aug 24. J Clin Endocrinol Metab. 2011. PMID: 21865356

10

Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma.

Diessl S, Holzberger B, Mäder U, Grelle I, Smit JW, Buck AK, Reiners C, Verburg FA. Diessl S, et al. Among authors: buck ak. Clin Endocrinol (Oxf). 2012 Apr;76(4):586-92. doi: 10.1111/j.1365-2265.2011.04272.x. Clin Endocrinol (Oxf). 2012. PMID: 22059804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page